Recordati Industria Chimica e Farmaceutica SpA 2025 AR2
The report outlines Recordati's financial and sustainability performance for the fiscal year 2025, highlighting its strategic progress and commitment to responsible growth. The company achieved double-digit revenue growth of 11.8% and expanded its rare diseases portfolio with key regulatory approvals, including the US label extension for Isturisa. On the environmental front, Recordati completed major solar panel installations in Italy, Tunisia, and Spain, reaching a total installed capacity of approximately 6,200 kWp. Additionally, the group advanced its diversity and inclusion agenda, achieving a 36% representation of women in top and senior management positions and conducting its second global employee engagement survey.
Company: Recordati Industria Chimica e Farmaceutica SpA
Sector: Manufacturing
Country: Italy
Year: 2025
Type: AR2
Pages: 350
Recordati Industria Chimica e Farmaceutica SpA
The report outlines Recordati's financial and sustainability performance for the fiscal year 2025, highlighting its strategic progress and commitment to responsible growth. The company achieved double-digit revenue growth of 11.8% and expanded its rare diseases portfolio with key regulatory approvals, including the US label extension for Isturisa. On the environmental front, Recordati completed major solar panel installations in Italy, Tunisia, and Spain, reaching a total installed capacity of approximately 6,200 kWp. Additionally, the group advanced its diversity and inclusion agenda, achieving a 36% representation of women in top and senior management positions and conducting its second global employee engagement survey.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees